Ozempic's Potential to Curb Alcohol Consumption and Treat Addiction
TL;DR Summary
GLP-1 receptor agonists, drugs primarily used for weight loss and diabetes, are showing potential in treating addiction by reducing cravings for substances like alcohol and drugs. Anecdotal evidence and preliminary research suggest these drugs may affect dopamine levels in the brain, which could explain their impact on addiction. However, experts caution that more rigorous clinical trials are needed to confirm their efficacy and safety for treating substance use disorders.
- Could Ozempic treat addiction? The Washington Post
- Ozempic and other weight loss drugs could be making people drink less, study says Quartz
- Dizzy after one drink? Social drinkers on obesity drugs lose the taste for alcohol NPR
- Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup Yahoo! Voices
- GLP-1s Hold Promise for Addiction but Questions Remain Medscape
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
6 min
vs 7 min read
Condensed
95%
1,354 → 69 words
Want the full story? Read the original article
Read on The Washington Post